180 related articles for article (PubMed ID: 20055587)
41. Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia.
Balode D; Westman M; Kolupajeva T; Rozentale B; Albert J
J Med Virol; 2010 Dec; 82(12):2013-8. PubMed ID: 20981787
[TBL] [Abstract][Full Text] [Related]
42. Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.
de Mulder M; Yebra G; Navas A; Martin L; de Jose MI; Navarro ML; de Ory SJ; Gonzalez-Granado I; Mellado MJ; Ramos JT; Holguin A
Pediatr Infect Dis J; 2012 Nov; 31(11):e213-21. PubMed ID: 22785049
[TBL] [Abstract][Full Text] [Related]
43. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
[TBL] [Abstract][Full Text] [Related]
44. Molecular and epidemiological characterization of HIV-1 infection networks involving transmitted drug resistance mutations in Northern Greece.
Skoura L; Metallidis S; Buckton AJ; Mbisa JL; Pilalas D; Papadimitriou E; Papoutsi A; Haidich AB; Chrysanthidis T; Tsachouridou O; Antoniadou ZA; Kollaras P; Nikolaidis P; Malisiovas N
J Antimicrob Chemother; 2011 Dec; 66(12):2831-7. PubMed ID: 21933785
[TBL] [Abstract][Full Text] [Related]
45. Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012).
Ambrosioni J; Sued O; Nicolas D; Parera M; López-Diéguez M; Romero A; Agüero F; Marcos MÁ; Manzardo C; Zamora L; Gómez-Carrillo M; Gatell JM; Pumarola T; Miró JM
PLoS One; 2015; 10(6):e0125837. PubMed ID: 26039689
[TBL] [Abstract][Full Text] [Related]
46. HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China.
Pang X; Tang K; He Q; Huang J; Fang N; Zhou X; Zhu Q; Wu X; Shen Z; Liang S
BMC Infect Dis; 2021 Feb; 21(1):160. PubMed ID: 33557775
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America.
Murillo W; Lorenzana de Rivera I; Albert J; Guardado ME; Nieto AI; Paz-Bailey G
J Med Virol; 2012 Oct; 84(10):1514-21. PubMed ID: 22930496
[TBL] [Abstract][Full Text] [Related]
48. Detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast Brazil.
Santos LA; Monteiro-Cunha JP; Araujo AF; Brites C; Galvao-Castro B; Alcantara LC
J Med Virol; 2011 Dec; 83(12):2066-72. PubMed ID: 22012712
[TBL] [Abstract][Full Text] [Related]
49. Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India.
Arora SK; Gupta S; Toor JS; Singla A
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):125-30. PubMed ID: 18240959
[TBL] [Abstract][Full Text] [Related]
50. Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences.
Balotta C; Facchi G; Violin M; Van Dooren S; Cozzi-Lepri A; Forbici F; Bertoli A; Riva C; Senese D; Caramello P; Carnevale G; Rizzardini G; Cremonini L; Monno L; Rezza G; Perno CF; Ippolito G; d'Arminio-Monforte A; Vandamme AM; Moroni M;
J Acquir Immune Defic Syndr; 2001 Aug; 27(5):499-505. PubMed ID: 11511828
[TBL] [Abstract][Full Text] [Related]
51. Prevalence of transmitted HIV-1 drug resistance remains low in Guangxi, China, eight years after scale-up of highly-active antiretroviral therapy.
Li G; Liang S; Harrison TJ; Tang Z; Shen Z; Wang X; Wu X; Liu W; Liang F; Feng L; Yang J; Fang Z
Intervirology; 2014; 57(5):270-6. PubMed ID: 24994115
[TBL] [Abstract][Full Text] [Related]
52. Surveillance of HIV drug resistance transmission in Iran: experience gained from a pilot study.
Mousavi SM; Hamkar R; Gouya MM; Safaie A; Zahraei SM; Yazdani Z; Asbaghi Namini S; Bertagnolio S; Sutherland D; Sandstrom P; Brooks J
Arch Virol; 2010 Mar; 155(3):329-34. PubMed ID: 20052598
[TBL] [Abstract][Full Text] [Related]
53. Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.
Tebit DM; Sangaré L; Tiba F; Saydou Y; Makamtse A; Somlare H; Bado G; Kouldiaty BG; Zabsonre I; Yameogo SL; Sathiandee K; Drabo JY; Kräusslich HG
J Med Virol; 2009 Oct; 81(10):1691-701. PubMed ID: 19697403
[TBL] [Abstract][Full Text] [Related]
54. High HIV-1 Diversity and Prevalence of Transmitted Drug Resistance Among Antiretroviral-Naive HIV-Infected Pregnant Women from Rio de Janeiro, Brazil.
Delatorre E; Silva-de-Jesus C; Couto-Fernandez JC; Pilotto JH; Morgado MG
AIDS Res Hum Retroviruses; 2017 Jan; 33(1):68-73. PubMed ID: 27392995
[TBL] [Abstract][Full Text] [Related]
55. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
[TBL] [Abstract][Full Text] [Related]
56. Epidemiological network analysis in HIV-1 B infected patients diagnosed in Italy between 2000 and 2008.
Callegaro A; Svicher V; Alteri C; Lo Presti A; Valenti D; Goglio A; Salemi M; Cella E; Perno CF; Ciccozzi M; Maggiolo F
Infect Genet Evol; 2011 Apr; 11(3):624-32. PubMed ID: 21292031
[TBL] [Abstract][Full Text] [Related]
57. Geographic and temporal trends of transmitted HIV-1 drug resistance among antiretroviral-naïve subjects screening for two clinical trials in North America and Western Europe.
Rahim S; Fredrick LM; da Silva BA; Bernstein B; King MS
HIV Clin Trials; 2009; 10(2):94-103. PubMed ID: 19487179
[TBL] [Abstract][Full Text] [Related]
58. Characteristics of HIV-1 non-B subtype infections in Northwest Poland.
Parczewski M; Leszczyszyn-Pynka M; Bander D; Urbańska A; Stańczak G; Boroń-Kaczmarska A
J Med Virol; 2010 Aug; 82(8):1306-13. PubMed ID: 20578066
[TBL] [Abstract][Full Text] [Related]
59. Molecular transmission network analysis of newly diagnosed HIV-1 infections in Nanjing from 2019 to 2021.
Shi H; Li X; Wang S; Dong X; Qiao M; Wu S; Wu R; Yuan X; Wang J; Xu Y; Zhu Z
BMC Infect Dis; 2024 Jun; 24(1):583. PubMed ID: 38867161
[TBL] [Abstract][Full Text] [Related]
60. HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil.
Cardoso LP; Pereira GA; Viegas AA; Schmaltz LE; Stefani MM
J Med Virol; 2010 Mar; 82(3):351-7. PubMed ID: 20087934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
